PT96135A - Processo para a preparacao de analogos peptido de somatostatina tendo treonina na sexta posicao - Google Patents

Processo para a preparacao de analogos peptido de somatostatina tendo treonina na sexta posicao

Info

Publication number
PT96135A
PT96135A PT96135A PT9613590A PT96135A PT 96135 A PT96135 A PT 96135A PT 96135 A PT96135 A PT 96135A PT 9613590 A PT9613590 A PT 9613590A PT 96135 A PT96135 A PT 96135A
Authority
PT
Portugal
Prior art keywords
alkyl
treonine
preparing
peptide analogues
phenylalkyl
Prior art date
Application number
PT96135A
Other languages
English (en)
Other versions
PT96135B (pt
Inventor
David Howard Coy
William A Murphy
Original Assignee
Univ Tulane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tulane filed Critical Univ Tulane
Publication of PT96135A publication Critical patent/PT96135A/pt
Publication of PT96135B publication Critical patent/PT96135B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/655Somatostatins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/655Somatostatins
    • C07K14/6555Somatostatins at least 1 amino acid in D-form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/02Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/16Somatostatin; related peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/26Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT96135A 1989-12-08 1990-12-07 Processo para a preparacao de analogos peptido de somatostatina tendo treonina na sexta posicao PT96135B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44787689A 1989-12-08 1989-12-08

Publications (2)

Publication Number Publication Date
PT96135A true PT96135A (pt) 1991-09-30
PT96135B PT96135B (pt) 1998-04-30

Family

ID=23778103

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96135A PT96135B (pt) 1989-12-08 1990-12-07 Processo para a preparacao de analogos peptido de somatostatina tendo treonina na sexta posicao

Country Status (14)

Country Link
US (1) US5506339A (pt)
EP (1) EP0457888B1 (pt)
JP (1) JP2925321B2 (pt)
KR (1) KR920702854A (pt)
AT (1) ATE140237T1 (pt)
CA (1) CA2046594A1 (pt)
DE (1) DE69027767T2 (pt)
DK (1) DK0457888T3 (pt)
ES (1) ES2091907T3 (pt)
GR (1) GR3020513T3 (pt)
HU (1) HUT59166A (pt)
PT (1) PT96135B (pt)
WO (1) WO1991009056A1 (pt)
ZA (1) ZA909896B (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU207104B (en) * 1991-01-25 1993-03-01 Biosignal Kutato Fejlesztoe Kf Process for producing new somatostatin analogs inhibiting tumour growth and pharmaceutical compositions comprising such compounds
US7238340B1 (en) * 1991-11-27 2007-07-03 Cis Bio International Monoamine, diamide, thiol-containing metal chelating agents
CA2079896A1 (en) * 1991-02-08 1992-08-09 Arthur E. Bogden Method of treating benign and malignant proliferative skin disease
US5411943A (en) * 1992-02-25 1995-05-02 Biomeasure, Inc. Hepatoma treatment with somatostatin analogs
US5716596A (en) * 1992-06-23 1998-02-10 Diatide, Inc. Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses
US5871711A (en) * 1992-06-23 1999-02-16 Diatide, Inc. Radioactively-labeled somatostatin-derived peptides for imaging and therapeutic uses
ATE206307T1 (de) * 1992-07-27 2001-10-15 Univ Tulane Antagonisten des neuromedin b rezeptors
US5569741A (en) * 1992-07-27 1996-10-29 Biomeasure, Inc. Cyclic octapeptide neuromedin B receptor antagonists
US5462926A (en) * 1992-07-27 1995-10-31 Biomeasure, Inc. Neuromedin B receptor antagonists which demonstrate selectivity
US5932189A (en) * 1994-07-29 1999-08-03 Diatech, Inc. Cyclic peptide somatostatin analogs
US5597894A (en) * 1995-06-05 1997-01-28 The Louisiana State University Medical Center Foundation Multi-tyrosinated somatostatin analogs
US5708135A (en) * 1995-09-29 1998-01-13 Biomeasure Incorporated Cyclic peptide analogs of somatostatin
US6262229B1 (en) 1996-12-04 2001-07-17 Biomeasure Incorporated Somatostatin antagonists
US6004928A (en) * 1997-05-13 1999-12-21 Biomeasure, Incorporated Method of treating hyperlipidemia
US7026289B2 (en) 1997-05-13 2006-04-11 Societe De Conseils De Recherches Et D'applications Scientifiques, Sas Method and compositions for treating hyperlipidemia and other conditions
EP0980253B1 (en) * 1997-05-13 2004-03-31 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Somatostatin and somatostatin agonists for treating insulin insensitivity and syndrome x
CA2290592A1 (en) 1997-05-13 1998-11-19 Michael Anthony Cawthorne Somatostatin and somatostatin agonists for decreasing body weight
PL346361A1 (en) * 1998-07-30 2002-02-11 Sod Conseils Rech Applic Methods of using a somatostatin analogue
EP1291022A1 (en) * 1998-07-30 2003-03-12 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Methods of using lanreotide, a somatostatin analogue
EP1372688B1 (en) * 2001-03-08 2008-05-07 The Administrators of The Tulane Educational Fund Somatostatin antagonists
MXPA03009048A (es) * 2001-04-09 2004-02-12 Univ Tulane Agonistas de la somatostatina.
CN1514843A (zh) 2001-06-08 2004-07-21 �о���Ӧ�ÿ�ѧЭ��ɷ����޹�˾ 生长激素释放抑制因子-多巴胺嵌合类似物
CA2523197C (en) 2003-04-22 2016-05-24 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Peptide vectors
US20110171191A1 (en) 2008-06-12 2011-07-14 Syntaxin Limited Suppression of neuroendocrine diseases
AU2009259034B2 (en) 2008-06-12 2013-10-31 Ipsen Bioinnovation Limited Suppression of cancers
GB0820970D0 (en) 2008-11-17 2008-12-24 Syntaxin Ltd Suppression of cancer
JP6869720B2 (ja) 2013-06-13 2021-05-12 アンチセンス セラピューティクス リミテッド 併用療法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4291022A (en) * 1975-03-11 1981-09-22 Sandoz Ltd. Organic compounds
DE19375086I2 (de) * 1979-11-27 2003-01-09 Novartis Ag Polypeptide Verfahren zu ihrer Herstellung pharmazeutische Zusammensetzungen die diese Polypeptide enthalten und ihre Verwendung
US4328105A (en) * 1980-02-06 1982-05-04 Linde Aktiengesellschaft Treatment of suspended solids--and adsorbable contaminant--containing liquid
US4328135A (en) * 1980-06-13 1982-05-04 American Home Products Corporation Octapeptides lowering growth hormone
US4282143A (en) * 1980-06-13 1981-08-04 American Home Products Corporation Octapeptides lowering growth hormone
DK81082A (da) * 1981-03-06 1982-09-07 Sandoz Ag Fremgangsmaade til fremstilling af polypeptider
US4485101A (en) * 1983-10-11 1984-11-27 Administrators Of The Tulane Educational Fund Peptides
US4684620A (en) * 1984-09-04 1987-08-04 Gibson-Stephens Neuropharmaceuticals, Inc. Cyclic polypeptides having mu-receptor specificity
US4725577A (en) * 1985-04-25 1988-02-16 Administrators Of The Tulane Educational Fund Biologically active lysine containing octapeptides
US4650787A (en) * 1985-04-25 1987-03-17 Schally Andrew Victor Biologically active octapeptides
US4904642A (en) * 1985-09-12 1990-02-27 The Administrators Of The Tulane Educational Fund Therapeutic somatostatin analogs
US4853371A (en) * 1986-06-17 1989-08-01 The Administrators Of The Tulane Educational Fund Therapeutic somatostatin analogs
JP2568228B2 (ja) * 1987-02-03 1996-12-25 ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド 治療用ソマトスタチンアナログ
JP2809403B2 (ja) * 1987-07-07 1998-10-08 ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド 治療用ソマトスタチンアナログ化合物
GB8813160D0 (en) * 1988-06-03 1988-07-06 Soc D Etudes Prod Chimique Therapeutic methods

Also Published As

Publication number Publication date
DK0457888T3 (da) 1996-08-12
ATE140237T1 (de) 1996-07-15
WO1991009056A1 (en) 1991-06-27
GR3020513T3 (en) 1996-10-31
EP0457888A1 (en) 1991-11-27
JPH04505456A (ja) 1992-09-24
DE69027767T2 (de) 1997-01-02
EP0457888B1 (en) 1996-07-10
KR920702854A (ko) 1992-10-28
HUT59166A (en) 1992-04-28
US5506339A (en) 1996-04-09
CA2046594A1 (en) 1991-06-09
ZA909896B (en) 1991-09-25
PT96135B (pt) 1998-04-30
DE69027767D1 (de) 1996-08-14
JP2925321B2 (ja) 1999-07-28
EP0457888A4 (en) 1992-01-02
ES2091907T3 (es) 1996-11-16

Similar Documents

Publication Publication Date Title
PT96135A (pt) Processo para a preparacao de analogos peptido de somatostatina tendo treonina na sexta posicao
BR8901037A (pt) Compostos,mistura sensivel a luz e processo para a preparacao de um composto
BR8705924A (pt) Mistura fotossensivel,material de registro contendo a mesma,e processo para producao de imagens em relevo utilizando tal material
BR9916027A (pt) Análogos de glp-1
ES2097174T3 (es) Derivados de la 2-ciclohexan-1-il amina.
CA2004991A1 (en) Deletion analogues of magainin peptides
ATE100132T1 (de) Fluessigkristalline, insbesondere ferroelektrische fluessigkristalline mischungen.
PT96381A (pt) Processo para a preparacao de derivados de 2-aminopirimidina-4-carboxamida e de composicoes farmaceuticas que os contem
BR9106523A (pt) Processo para a preparacao de uma solucao aquosa de compostos de sodio
BR9204852A (pt) Mistura estabilizante,composicao,uso de uma mistura e processo para estabilizar composicoes
BR1100379A (pt) Composto, uso de um composto, preparação farmacêutica e processo para preparação de um composto
BR9106744A (pt) Processo para induzir diferenciacao celular,preparacao farmaceutica,composicao e uso de um composto
PT92540A (pt) Processo para a preparacao de derivados de anfotericina b
BR8904806A (pt) Processo para a preparacao de mercapto-bis-(1,3,4-oxa e tiadiazois)e composicao praguicida
SE8904127D0 (sv) New biocyclic amino-substituted compounds
PT95112A (pt) Processo para a preparacao de derivados de peptido farmacologicamente activos
AU8653891A (en) Amino acid analogs as cck antagonists
GB2135997B (en) N-(m-trifluoromethylphenyl)-n'-propargylpiperazine
BR9507976A (pt) Mistura fungicida processo para controlar fungos nocivos e uso de um composto
ES2036215T3 (es) Nuevos derivados de na n-(2,4,6-trimetoxibenzoil)-3-propil) peperidina, sus procedimientos preparacion y su aplicacion en terapeutica.
DE3262231D1 (en) A novel vasodilator compound, process for the preparation thereof and pharmaceutical compositions thereform
FI961423A0 (fi) Antrasykliinidisakkaridit, menetelmä niiden valmistamiseksi sekä niitä sisältävät farmaseuttiset koostumukset
DK551487D0 (da) 1-hydroxyalkylxanthiner samt farmaceutiske praeparater med indhold af saadanne forbindelser
ES523235A0 (es) "procedimiento para la preparacion de n-(2-(((5-(dimetilamino)-metil-2-furanil) metil) tio) etil) -n'- metil-2-nitro 1,1-etenodiamina"
ITMI913295A1 (it) Procedimento di avanzamento di gallerie come pure macchine di avanzamento a scudo per l'attuazione di questo procedimento

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910430

FG3A Patent granted, date of granting

Effective date: 19980107

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20020731

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20020731